nsc 330770 has been researched along with vincristine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comber, RN; Rener, GA; Temple, C | 1 |
| Comber, RN; Elliott, RD; Kussner, CL; Montgomery, JA; Rose, JD; Temple, C; Wheeler, GP | 1 |
2 other study(ies) available for nsc 330770 and vincristine
| Article | Year |
|---|---|
New anticancer agents: alterations of the carbamate group of ethyl (5-amino-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl)car bamates.
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Survival; Indicators and Reagents; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Pyridazines; Structure-Activity Relationship; Tumor Cells, Cultured | 1989 |
New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines).
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Folic Acid Antagonists; Leukemia L1210; Leukemia P388; Mice; Mitosis; Pyrazines; Pyridines | 1982 |